Advantages

«BioEq» is experienced in conducting complex, intensive early and late stage clinical research and bioequivalence clinical trials.

We offer:

  • First feedback about the study and signing of a CDA within 12-24 hours
  • Feasibility completion in the shortest possible time (3 – 5 business days)
  • Commercial proposal within 3 business days
  • Experienced and dedicated staff (~ 150 ppl)
  • A pull of KOLs to participate as PIs and a clear division of responsibilities within a study team
  • Proven expertise in early phase studies
  • Experience in phase II-III studies
  • Preparation of the unit for the start-up: pre-screening of subjects before the start-up, speedy and high-quality enrollment starting from the first day after the start up
  • Screening within 1-2 days due to a big database of volunteers that is maintained on the ongoing basis
  • High-quality recruitment of patients: established relationship with and an implemented motivation system of referrals, constant management of referrals
  • Protocol expertise
  • Prepared project-specific source documentation templates 
  • Annual equipment check, contracts with main vendors
  • Possibility to provide necessary documentation within 12 hours
  • State-of-the-art facilities
  • Implemented quality management system
  • Fast agreement signature process (not longer than 1-2 weeks)
  • LEC review upon request
  • LEC review before MoH approval which helps to speed up site start-up period of the trial
  • Commitment to quality and the principles of Good Clinical Practice and applicable legislation
  • Capacity to carry out multiple, complex, procedurally intensive studies simultaneously
  • Customized solutions in the drug development process and quick response for the queries

We are interested in long-term relationship with our clients, that is why we try to make all possible efforts to perform clinical trials on time and with great quality.